Aeson Artificial heart from Carmat. The first biocompatible, biventricular mechanical heart
Carmat has developed a biocompatible, biventricular mechanical heart
To simulate the functionality and morphology of the human heart as closely as possible using self-regulatory mechanisms and biocompatible materials.
It aims to provide long term. A solution for patients with advanced biventricular HF and possibly acute myocardial infarction (MI) for whom no human transplant or the possibilities of treatment are available.
The device recently won regulatory approval from European Commission.
It now plans to begin sales in the second quarter of this year